Creating Agile Drug Development for Pandemics: Gareth Griffiths, Professor of Clinical Trials at University of Southampton & Saye Khoo, Professor of Pharmacology & Therapeutics at University of Liverpool

Redesigning conventional drug development to function efficiently during COVID-19 and other pandemics is essential. This week I had the opportunity to chat with two gentlemen who are invested in doing this critically important work.  Professor Gareth Griffiths and Professor Saye Khoo explain how their platform, AGILE, is recreating conventional drug development. Take a listen below.


Learn more about W2O via our About or Healthcare pages

Don’t miss an episode of What2Know, subscribe to our podcast on iTunesStitcher or Spotify!

Aaron Strout
Aaron Strout

Leave a Reply

Your email address will not be published.